Home/ Supplements/ Tyrosine/ Ultimate Longevity Formula

Ultimate Longevity Formula

product on market Powder Prime by Isotonix Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 29% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains branched-chain amino acids and protein, which have strong evidence for supporting muscle protein synthesis and recovery. Potassium serves as an essential electrolyte for cellular function. Overall, the evidence coverage for this specific ingredient profile is very limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Ultimate Longevity Formula
Open Full PDF View on NIH DSLD →
Details

Label Data

10 Gram(s)
Serving Size
30
Servings
Other Combinations
Product Type
29%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
15 Calorie(s)
Total Carbohydrates
4 Gram(s) (1% DV)
Protein
3 Gram(s)
Potassium
300 mg (6% DV)
Market median: 500.0mg (180 products) 5 studies (A:0, B:1)
Market median: 100.0mg (284 products) 10 studies (A:0, B:4)
100 mcg
Market median: 0.15mg (41 products)

Other Ingredients

Fructose Citric Acid Malic Acid Orange Juice, Powder Orange Flavor Silicon Dioxide Rebaudioside A Luo Han Guo fruit extract Stearic Acid
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions for use: Pour 3 level, white bottle capfuls of powder into a cup. Add 6 fl oz/180 mL (line on the overcap indicates 2 fl oz/60 mL) of water and stir. As a dietary supplement, take once daily or as directed by your healthcare provider. Do not exceed 2 servings (6 capfuls) per day. Maximum absorption occurs when taken on an empty stomach. This product is isotonic only if the specified amounts of powder and water are used.

Warnings & Precautions

Do not exceed 2 servings (6 capfuls) per day.

Warning: If you are currently using anticholinergic drugs, warfarin (Coumadin), other antiplatelet/anticoagulant drugs, or levodopa, consult your healthcare provider before using this product. If you are currently using any other prescription drugs or have an ongoing medical condition, consult your healthcare provider before using this product. If you are pregnant or breastfeeding, do not use this product. This supplement contains Huperzine A. Huperzine A is a reversible inhibitor of acetylcholinesterase and may cause cholinergic side effect. Caution should be used if you are taking drugs that promote or suppress acetylcholine activity.

Keep out of the reach of children.

Do not use if safety seal is broken or missing.

Resale on third-party websites is strictly prohibited unless specifically authorized by Market America or its corporate affiliates. If barcodes are altered or you purchase this product from an unauthorized third-party website, the product is not guaranteed by Market America or its corporate affiliates.

Contains: Soy.

Formulation Notes

Promotes healthy muscle retention and use Aids in improving and enhancing memory Helps reduce muscle fatigue

Anti-aging nutraceuticals

This product contains no added wheat, yeast, gluten, artificial flavor, starch, salt, preservatives or milk.

Manufactured in an FDA Registered Facility using Good Manufacturing Practices (GMPs).

Additional Information

Store in a cool, dry place.

Metadata

Product Details

UPC / SKU8 48570 00632 5
DSLD Entry Date2024-07-25
Product TypeOther Combinations
FormPowder
DSLD ID313433
Data Updated2026-04-11
Research

Research Evidence

50
Research Sources
47
Avg Quality
28
Rct
13
Clinical Trial
5
Guideline
4
Systematic Review
A Using a Novel Consensus-Based Chemoinformatics Approach to Predict ADMET Properties and Druglikeness of Tyrosine Kinase Inhibitors.
Guideline International journal of molecular sciences 2025 PubMed DOI
B Australia and New Zealand consensus statement on the cardiovascular management of patients with chronic lymphocytic leukaemia treated with Bruton's tyrosine kinase inhibitors.
Guideline Internal medicine journal 2025 PubMed DOI
B Branched-chain amino acid supplementation for improving growth and development in term and preterm neonates
Systematic Review The Cochrane database of systematic reviews 2020 PubMed DOI
B [Clinical practice guideline on anaplastic lymphoma kinase-tyrosine kinase inhibitors for non-small cell lung cancer (2025 edition)].
Guideline Zhonghua zhong liu za zhi [Chinese journal of oncology] 2025 PubMed DOI
B [Chinese expert consensus on epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer (2025 edition)].
Guideline Zhonghua yi xue za zhi 2025 PubMed DOI
B Consensus Guideline for the Diagnosis and Treatment of Tyrosine Hydroxylase (TH) Deficiency.
Guideline Journal of inherited metabolic disease 2025 PubMed DOI
B Baseline-dependent effect of dopamine's precursor L-tyrosine on working memory gating but not updating
Rct Cognitive, affective & behavioral neuroscience 2020 PubMed DOI
B Effect of Amino Acid Supplementation on Iron Regulation after Endurance Exercise
Rct Nutrients 2023 PubMed DOI
C Attenuating Muscle Damage Biomarkers and Muscle Soreness After an Exercise-Induced Muscle Damage with Branched-Chain Amino Acid (BCAA) Supplementation: A Systematic Review and Meta-analysis with Meta-regression
Systematic Review Sports medicine - open 2024 PubMed DOI
C The Effects of Green Tea Amino Acid L-Theanine Consumption on the Ability to Manage Stress and Anxiety Levels: a Systematic Review
Systematic Review Plant foods for human nutrition (Dordrecht, Netherlands) 2020 PubMed DOI
View all evidence for Tyrosine →
Compare

Similar Products

View all Tyrosine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.